HELIOS Advanced: Human Oocyte Illumination to Enhance Development
Recruiting
N/A
Interventional Study
IVF Outcomes
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 48
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 270 (estimated)
- Sponsor
- Columbia University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Oocytes need a lot of energy to complete meiosis and fertilize successfully. As women get older, the "power plants" of the cells (called mitochondria) don't work as well. This makes it harder for eggs and embryos to develop normally. One possible way to help is with a gentle light treatment called photobiomodulation (PBM). This uses a special type of red light that boosts energy production in cell…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female age between 18-48 years at the time of the IVF/ICSI cycle
* Undergoing blastocyst culture
* Using own oocytes
* Has at least two oocytes available for randomization
* Consenting to oocyte level randomization
* Plan to transfer euploid embryo within 6 months
Exclusion C…
Contacts